Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.
- DOI
- 10.1136/jmedgenet-2018-105454
- Published
- 2019 Jan
- Container
- Journal of medical genetics
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1136/jmedgenet-2018-105454,
title = {Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.},
author = {Chen D and Chen W and Xu Y and Zhu M and Xiao Y and Shen Y and Zhu S and Cao C and Xu X},
year = {2019},
journal = {Journal of medical genetics},
doi = {10.1136/jmedgenet-2018-105454},
url = {https://doi.org/10.1136/jmedgenet-2018-105454}
}RIS
TY - JOUR TI - Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target. AU - Chen D AU - Chen W AU - Xu Y AU - Zhu M AU - Xiao Y AU - Shen Y AU - Zhu S AU - Cao C AU - Xu X PY - 2019 JO - Journal of medical genetics DO - 10.1136/jmedgenet-2018-105454 UR - https://doi.org/10.1136/jmedgenet-2018-105454 ER -
APA
D, C., W, C., Y, X., M, Z., Y, X., Y, S., S, Z., C, C., & X, X. (2019). Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target.. Journal of medical genetics. https://doi.org/10.1136/jmedgenet-2018-105454
Source records
- pubmed · retrieved 2026-09-26T03:10:10.714Z